mirage

Rationale and methods of the multicenter randomised trial of a heart failure management programme among geriatric patients (HF-Geriatrics)

ABACUS/Manakin Repository

Show simple item record

dc.contributor.author Rodríguez Pascual, Carlos spa
dc.contributor.author Paredes Galán, Emilio spa
dc.contributor.author González Guerrero, José Luís spa
dc.contributor.author Menéndez Colino, Rocío spa
dc.contributor.author Abizanda Soler, Pedro spa
dc.contributor.author Hornillos Calvo, Mercedes spa
dc.contributor.author Solano Jaurieta, Juan José spa
dc.contributor.author Manzarbeitia Arambarri, Jorge spa
dc.contributor.author Ribera Casado, José Manuel spa
dc.contributor.author Rodríguez-Artalejo, Fernando spa
dc.date.accessioned 2013-11-27T17:26:37Z
dc.date.available 2013-11-27T17:26:37Z
dc.date.issued 2011 spa
dc.identifier.citation Rodríguez-Pascual, C., Paredes-Galán, E., González-Guerrero, J. L., Menéndez-Colino, R., Abizanda-Soler, P., Hornillos-Calvo, M., ..., & Rodríguez-Artalejo, F. (2011). Rationale and methods of the multicenter randomised trial of a heart failure management programme among geriatric patients (HF-Geriatrics). BMC Public Health, 11(1), 627. spa
dc.identifier.issn 14712458 spa
dc.identifier.uri http://hdl.handle.net/11268/905
dc.description.abstract Background: Disease management programmes (DMPs) have been shown to reduce hospital readmissions and mortality in adults with heart failure (HF), but their effectiveness in elderly patients or in those with major comorbidity is unknown. The Multicenter Randomised Trial of a Heart Failure Management Programme among Geriatric Patients (HF-Geriatrics) assesses the effectiveness of a DMP in elderly patients with HF and major comorbidity. Methods/Design: Clinical trial in 700 patients aged >= 75 years admitted with a primary diagnosis of HF in the acute care unit of eight geriatric services in Spain. Each patient should meet at least one of the following comorbidty criteria: Charlson index >= 3, dependence in >= 2 activities of daily living, treatment with >= 5 drugs, active treatment for >= 3 diseases, recent emergency hospitalization, severe visual or hearing loss, cognitive impairment, Parkinson's disease, diabetes mellitus, chronic obstructive pulmonary disease (COPD), anaemia, or constitutional syndrome. Half of the patients will be randomly assigned to a 1-year DMP led by a case manager and the other half to usual care. The DMP consists of an educational programme for patients and caregivers on the management of HF, COPD (knowledge of the disease, smoking cessation, immunizations, use of inhaled medication, recognition of exacerbations), diabetes (knowledge of the disease, symptoms of hyperglycaemia and hypoglycaemia, self-adjustment of insulin, foot care) and depression (knowledge of the disease, diagnosis and treatment). It also includes close monitoring of the symptoms of decompensation and optimisation of treatment compliance. The main outcome variables are quality of life, hospital readmissions, and overall mortality during a 12-month follow-up. Discussion: The physiological changes, lower life expectancy, comorbidity and low health literacy associated with aging may influence the effectiveness of DMPs in HF. The HF-Geriatrics study will provide direct evidence on the effect of a DMP in elderly patients with HF and high comorbidty, and will reduce the need to extrapolate the results of clinical trials in adults to elderly patients. spa
dc.language.iso eng spa
dc.subject.other Home-Based Intervention spa
dc.subject.other Quality-Of-Life spa
dc.subject.other Hospital Readmission spa
dc.subject.other Older spa
dc.subject.other Patients spa
dc.subject.other Follow-Up spa
dc.subject.other Disease spa
dc.subject.other Metaanalysis spa
dc.subject.other Population spa
dc.subject.other Depression spa
dc.subject.other Mortality spa
dc.subject.other Public, Environmental & Occupational Health spa
dc.title Rationale and methods of the multicenter randomised trial of a heart failure management programme among geriatric patients (HF-Geriatrics) spa
dc.type article spa
dc.description.impact 1.997 JCR (2011) Q2, 60/158 Public, environmental & occupational health spa
dc.identifier.doi 10.1186/1471-2458-11-627 spa
dc.rights.accessRights openAccess en
dc.subject.unesco Enfermedad cardiovascular spa
dc.subject.unesco Medicina preventiva spa
dc.peerreviewed Si spa


Files in this item

This item appears in the following Collection(s)

Show simple item record